Amphastar Pharma (NASDAQ: AMPH) reported Q1 EPS of $0.12, $0.15 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $59.4 million versus the consensus estimate of $62 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.